In profiling the expression of CYP enzymes in breast, ovary and colon cancers, CYP4Z1 was overexpressed in all tumours examined compared to normal tissues, and its expression in ovary cancer was suggested to be a biomarker for prognosis [12, 14–16]. Here, PPIG is linked to neoplasm.